Wunsch Scott M
Wunsch Scott M, CEO, reported a transaction classified as grant at Strata Critical Medical, Inc. involving 1416.000000 shares for an estimated $0.00. Reported holdings after the transaction were 791250.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Oct 28, 2026
- Filing date
- Oct 30, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
SRTA price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- grant Code A
- Identifier
- 0001628280-26-068567 Class A common stock, $0.0001 par value per share
- Transaction date
- Oct 28, 2026 Filed Oct 30, 2026, 08:06 PM · 2d delay
- Shares
- 1,416 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 791,250 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-12 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - grant_or_award-22 points
transaction_code = A
Grant or award transactions are scheduled compensation, not discretionary.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
CEO, Logistics
- F1
Represents a grant of Restricted Stock Units ("RSUs") which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will vest on September 8, 2026, subject to the Reporti…
- F2
Represents a grant of RSUs which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will vest on December 8, 2026, subject to the Reporting Person's continued servic…
- F3
Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performa…
- F4
Represents a grant of RSUs which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will vest on March 8, 2027, subject to the Reporting Person's continued service t…
- F5
Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs.
- F6
Held directly by a limited liability company of which the Reporting Person is the sole member.
0 other transactions
0 recent txs